Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Cancer Management and Research|May 17, 2014
Future of bisphosphonates and denosumab for men with advanced prostate cancerMaryam Iranikhah, Steve Stricker, Maisha Kelly Freeman
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|June 16, 2012
Tablet splitting: a review of the clinical and economic outcomes and patient acceptance. Second of a 2-part series. Part 1 was published in May 2012 (Consult Pharm 2012;27:239-53)Maisha Kelly Freeman, Whitney White, Maryam Iranikhah
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|May 18, 2012
Tablet splitting: a review of weight and content uniformityMaisha Kelly Freeman, Whitney White, Maryam Iranikhah
The Senior Care Pharmacist|July 1, 2020
Romosozumab and Sequential Therapy in Postmenopausal OsteoporosisRachel M Slaton, Katie Boyd, Maryam Iranikhah
Pharmacotherapy|October 4, 2012
Vilazodone for the treatment of major depressive disorderMaryam Iranikhah, Terri M Wensel, Angela R Thomason
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|May 4, 2018
Effects of Denosumab After Treatment Discontinuation : A Review of the LiteratureMaryam Iranikhah, Crystal Deas, Pilar Murphy, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|March 9, 2017
Retained Skeletal Effects of Zoledronic Acid Following Discontinuation of Treatment: A Review of the LiteratureCrystal M Deas, Pilar Murphy, Maryam Iranikhah, et al.
Pharmacotherapy|March 7, 2012
Denosumab for the prevention of skeletal-related events in patients with bone metastasis from solid tumorMaryam Iranikhah, Teresa W Wilborn, Terri M Wensel, et al.
The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists|July 13, 2018
Fracture Risk Following Discontinuation of Teriparatide: A Review of the LiteraturePilar Z Murphy, Maryam Iranikhah, Crystal M Deas, et al.
Pageof 1